BMRN
Price
$61.52
Change
+$0.27 (+0.44%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
11.67B
34 days until earnings call
FULC
Price
$3.96
Change
-$0.02 (-0.50%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
214.68M
41 days until earnings call
Ad is loading...

BMRN vs FULC

Header iconBMRN vs FULC Comparison
Open Charts BMRN vs FULCBanner chart's image
BioMarin Pharmaceutical
Price$61.52
Change+$0.27 (+0.44%)
Volume$53.79K
Capitalization11.67B
Fulcrum Therapeutics
Price$3.96
Change-$0.02 (-0.50%)
Volume$4.32K
Capitalization214.68M
BMRN vs FULC Comparison Chart
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. FULC commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Hold and FULC is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (BMRN: $61.25 vs. FULC: $3.98)
Brand notoriety: BMRN and FULC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 196% vs. FULC: 60%
Market capitalization -- BMRN: $11.67B vs. FULC: $214.68M
BMRN [@Biotechnology] is valued at $11.67B. FULC’s [@Biotechnology] market capitalization is $214.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $370.67B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileFULC’s FA Score has 1 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • FULC’s FA Score: 1 green, 4 red.
According to our system of comparison, FULC is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 4 TA indicator(s) are bullish while FULC’s TA Score has 4 bullish TA indicator(s).

  • BMRN’s TA Score: 4 bullish, 5 bearish.
  • FULC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FULC is a better buy in the short-term than BMRN.

Price Growth

BMRN (@Biotechnology) experienced а -10.43% price change this week, while FULC (@Biotechnology) price change was -11.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

BMRN is expected to report earnings on Apr 23, 2025.

FULC is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($11.7B) has a higher market cap than FULC($215M). BMRN YTD gains are higher at: -6.816 vs. FULC (-15.319). BMRN has higher annual earnings (EBITDA): 507M vs. FULC (-26.67M). BMRN has more cash in the bank: 930M vs. FULC (257M). FULC has less debt than BMRN: FULC (9.15M) vs BMRN (603M). BMRN has higher revenues than FULC: BMRN (2.75B) vs FULC (80.9M).
BMRNFULCBMRN / FULC
Capitalization11.7B215M5,442%
EBITDA507M-26.67M-1,901%
Gain YTD-6.816-15.31944%
P/E Ratio36.90N/A-
Revenue2.75B80.9M3,403%
Total Cash930M257M362%
Total Debt603M9.15M6,594%
FUNDAMENTALS RATINGS
BMRN: Fundamental Ratings
BMRN
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
81
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMRNFULC
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
70%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
63%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
64%
Bullish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 10 days ago
62%
Bullish Trend 15 days ago
88%
Declines
ODDS (%)
Bearish Trend 4 days ago
60%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
58%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with IBO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then IBO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-0.54%
IBO - BMRN
60%
Loosely correlated
-1.23%
ITOS - BMRN
39%
Loosely correlated
-0.39%
FULC - BMRN
35%
Loosely correlated
-2.93%
PRME - BMRN
32%
Poorly correlated
+0.35%
RCUS - BMRN
31%
Poorly correlated
-0.98%
More

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ONCT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ONCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-2.93%
ONCT - FULC
53%
Loosely correlated
N/A
INZY - FULC
51%
Loosely correlated
-1.45%
SCPH - FULC
40%
Loosely correlated
-2.29%
ANNX - FULC
40%
Loosely correlated
-3.07%
VRDN - FULC
40%
Loosely correlated
-1.90%
More